FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69059-y
Abstract: Although the cure rate for childhood acute lymphoblastic leukemia (ALL) has exceeded 80% with contemporary therapy, relapsed ALL remains a leading cause of cancer-related death in children. Relapse-specific mutations can be identified by comprehensive genome… read more here.
Keywords: specific mutations; relapse specific; childhood acute; acute lymphoblastic ... See more keywords